DrugPatentWatch Database Preview

Zogenix Inc Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ZOGENIX INC, and what generic alternatives to ZOGENIX INC drugs are available?

ZOGENIX INC has one approved drug.

There are ten US patents protecting ZOGENIX INC drugs.

There are forty-six patent family members on ZOGENIX INC drugs in twenty countries.

Summary for Zogenix Inc

International Patents:	46
US Patents:	10
Tradenames:	1
Ingredients:	1
NDAs:	1
Drug Master File Entries:	1

Drugs and US Patents for Zogenix Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zogenix Inc	FINTEPLA	fenfluramine hydrochloride	SOLUTION;ORAL	212102-001	Jun 25, 2020		RX	Yes	Yes	9,549,909
Zogenix Inc	FINTEPLA	fenfluramine hydrochloride	SOLUTION;ORAL	212102-001	Jun 25, 2020		RX	Yes	Yes	10,603,290
Zogenix Inc	FINTEPLA	fenfluramine hydrochloride	SOLUTION;ORAL	212102-001	Jun 25, 2020		RX	Yes	Yes	9,603,815
Zogenix Inc	FINTEPLA	fenfluramine hydrochloride	SOLUTION;ORAL	212102-001	Jun 25, 2020		RX	Yes	Yes	10,478,441
Zogenix Inc	FINTEPLA	fenfluramine hydrochloride	SOLUTION;ORAL	212102-001	Jun 25, 2020		RX	Yes	Yes	9,610,260
Zogenix Inc	FINTEPLA	fenfluramine hydrochloride	SOLUTION;ORAL	212102-001	Jun 25, 2020		RX	Yes	Yes
Zogenix Inc	FINTEPLA	fenfluramine hydrochloride	SOLUTION;ORAL	212102-001	Jun 25, 2020		RX	Yes	Yes	10,947,183		Y	Y

International Patents for Zogenix Inc Drugs

Country	Patent Number	Estimated Expiration
Japan	2020063309
South Africa	201705078
World Intellectual Property Organization (WIPO)	2014177676
Mexico	2017004065
Australia	2020202655
New Zealand	730560
Taiwan	201821071

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Zogenix Inc